Coegin Pharma (NGM:COEGIN) OCF Margin %: -1,926.37% (As of Mar. 2026)

What is Coegin Pharma OCF Margin %?

Coegin Pharma NGM:COEGIN -1.75% 30 OCF Margin % is -1,926.37% as of Mar. 2026. GuruFocus rates NGM:COEGIN with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Coegin Pharma ranks worse than 90.73% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Coegin Pharma's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-5.63 Mil. Coegin Pharma's Revenue for the three months ended in Mar. 2026 was kr0.29 Mil. Therefore, Coegin Pharma's OCF Margin % for the quarter that ended in Mar. 2026 was -1,926.37%.

As of today, Coegin Pharma's current OCF Yield % is -18.89%.

The historical rank and industry rank for Coegin Pharma's OCF Margin % or its related term are showing as below:

NGM:COEGIN' s OCF Margin % Range Over the Past 10 Years
Min: -21714.29 Med: -1866.67 Max: -27.33
Current: -4870.35

During the past 9 years, the highest OCF Margin % of Coegin Pharma was -27.33%. The lowest was -21714.29%. And the median was -1866.67%.

NGM:COEGIN's OCF Margin % is ranked worse than
90.73% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs NGM:COEGIN: -4870.35

Coegin Pharma OCF Margin % Related Terms

Coegin Pharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Coegin Pharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coegin Pharma OCF Margin % Chart

Coegin Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

0.00

-20,944.30

Coegin Pharma Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	-5,606.33	-1,926.37

NGM:COEGIN vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, Coegin Pharma's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coegin Pharma OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coegin Pharma's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Coegin Pharma's OCF Margin % falls into.

Save Embed

30GF Score

Coegin Pharma NGM:COEGIN

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Coegin Pharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Coegin Pharma's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-16.546	/	0.079
	=	-20,944.30 %

Coegin Pharma's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-5.625	/	0.292
	=	-1,926.37 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -1,926.37% mean?

Coegin Pharma (NGM:COEGIN) has a OCF Margin % of -1,926.37% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Coegin Pharma and its competitors. According to the industry distribution chart, Coegin Pharma ranks #871 out of 960 companies in the Biotechnology industry, placing it in the top 90.7%.

Is Coegin Pharma's OCF Margin % too high?

Coegin Pharma's current OCF Margin % is -1,926.37%. Based on the distribution chart, Coegin Pharma ranks #871 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Coegin Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does Coegin Pharma's OCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Coegin Pharma ranks #871 out of 960 companies for OCF Margin %. This places Coegin Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Coegin Pharma and its competitors. Coegin Pharma's current OCF Margin % is -1,926.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Coegin Pharma stock overvalued right now?

Coegin Pharma (NGM:COEGIN) has a current OCF Margin % of -1,926.37%. The current OCF Margin % is -1,926.37%. Coegin Pharma's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Coegin Pharma (NGM:COEGIN), the current OCF Margin % is -1,926.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coegin Pharma Business Description

Industry Healthcare Biotechnology

Comparable Companies FRA:T5O FRA:9RP VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270 RPRX BNTX INSM ROIV INCY MRNA HKSE:01801 HKSE:02269

Other Exchanges 7Z6:Germany

Address c/o Medicon Village, Lund, SWE, 223 81

Website https://www.coeginpharma.com

Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.

30GF Score

Get the complete analysis for NGM:COEGIN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.37

Price

View NGM:COEGIN Analysis

See OCF Margin % data for all stocks →